Milestone Pharmaceuticals Inc.
MIST- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001408443
No open-market purchases or sales by Milestone Pharmaceuticals Inc. insiders were filed in the last 90 days; 78 institutions reported holding it in 13F filings for Q2 2026, worth $66.4M in total; no superinvestor holds it.
13F holders, Q2 2024
Institutional positions in Milestone Pharmaceuticals Inc. as of Jun 30, 2024. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 40
- −3 vs. Q1 2024
- Shares held
- 30.2M
- −1.16M (−3.7%) vs. Q1 2024
- Total value
- $39.9M
- −$16.5M (−29.3%) vs. Q1 2024
- New holders
- 3
- 9 more added
- Sold out
- 6
- 6 more reduced
Compare with Q1 2024: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting MIST on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 78 | $66.4M |
| Q1 2026 | 87 | $47.2M |
| Q4 2025 | 80 | $70.7M |
| Q3 2025 | 61 | $68.3M |
| Q2 2025 | 43 | $22.9M |
| Q1 2025 | 43 | $9.46M |
| Q4 2024 | 47 | $57.9M |
| Q3 2024 | 43 | $43.6M |
| Q2 2024 | 40 | $39.9M |
| Q1 2024 | 43 | $56.4M |
| Q4 2023 | 40 | $29.7M |
| Q3 2023 | 39 | $60.7M |
| Q2 2023 | 48 | $59.0M |
| Q1 2023 | 50 | $85.5M |
| Q4 2022 | 56 | $96.9M |
| Q3 2022 | 47 | $198.7M |
| Q2 2022 | 29 | $127.2M |
| Q1 2022 | 28 | $135.1M |
| Q4 2021 | 28 | $132.6M |
| Q3 2021 | 27 | $113.9M |
| Q2 2021 | 28 | $110.8M |
| Q1 2021 | 34 | $117.4M |
Institutions, Q2 2024
Shares, value and share of portfolio for each institution holding Milestone Pharmaceuticals Inc.; share changes are against Q1 2024.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Barclays PLC | 100 | $132 | 0.00% | 00.0% | Unchanged |
| Oliver Lagore Vanvalin Investment Group | 100 | $132 | 0.00% | 00.0% | Unchanged |
| Qube Research & Technologies Ltd | 194 | $258 | 0.00% | 00.0% | Unchanged |
| Simplex Trading, LLC | 1,191 | $1.00K | 0.00% | +713+149.2% | Added |
| Jones Financial Companies LLLP | 1,070 | $1.41K | 0.00% | +1,070 | New |
| Advisor Group Holdings, Inc. | 6,500 | $8.58K | 0.00% | +500+8.3% | Added |
| National Bank of Canada | 7,100 | $9.40K | 0.00% | 00.0% | Unchanged |
| Valeo Financial Advisors, LLC | 10,000 | $13.2K | 0.00% | 00.0% | Unchanged |
| Federation des caisses Desjardins du Quebec | 10,500 | $13.9K | 0.00% | 00.0% | Unchanged |
| Creative Planning | 13,080 | $17.3K | 0.00% | 00.0% | Unchanged |
| Beta Wealth Group, Inc. | 14,127 | $18.6K | 0.01% | 00.0% | Unchanged |
| Geode Capital Management, LLC | 17,576 | $23.4K | 0.00% | 00.0% | Unchanged |
| State Street Corp | 18,923 | $25.2K | 0.00% | 00.0% | Unchanged |
| Clear Creek Financial Management, LLC | 19,500 | $25.7K | 0.00% | −5,500−22.0% | Reduced |
| Cetera Investment Advisers | 20,689 | $27.3K | 0.00% | +3,262+18.7% | Added |
| BNP Paribas Arbitrage, SA | 24,600 | $32.7K | 0.00% | +7,700+45.6% | Added |
| Northern Trust Corp | 27,784 | $36.7K | 0.00% | −532−1.9% | Reduced |
| Atria Investments LLC | 27,991 | $36.9K | 0.00% | +27,991 | New |
| Boothbay Fund Management, LLC | 30,779 | $40.6K | 0.00% | 00.0% | Unchanged |
| Dimensional Fund Advisors LP | 39,450 | $52.4K | 0.00% | 00.0% | Unchanged |
| Squarepoint Ops LLC | 54,684 | $72.7K | 0.00% | +54,684 | New |
| Envestnet Asset Management Inc | 59,523 | $78.6K | 0.00% | +7,690+14.8% | Added |
| Ancora Advisors, LLC | 60,000 | $79.2K | 0.00% | 00.0% | Unchanged |
| ADAR1 Capital Management, LLC | 202,460 | $267.2K | 0.05% | 00.0% | Unchanged |
| Boxer Capital, LLC | 309,007 | $407.9K | 0.02% | 00.0% | Unchanged |
| Ikarian Capital, LLC | 466,019 | $619.8K | 0.19% | 00.0% | Unchanged |
| Morgan Stanley | 828,654 | $1.09M | 0.00% | +8,826+1.1% | Added |
| Altium Capital Management LP | 1,012,368 | $1.34M | 0.55% | −200,514−16.5% | Reduced |
| BML Capital Management, LLC | 1,102,895 | $1.46M | 1.07% | +496,750+82.0% | Added |
| Stonepine Capital Management, LLC | 1,239,199 | $1.64M | 1.49% | −223,097−15.3% | Reduced |
| Bleichroeder LP | 1,326,085 | $1.75M | 0.52% | 00.0% | Unchanged |
| Goldman Sachs Group Inc | 1,353,067 | $1.79M | 0.00% | 00.0% | Unchanged |
| Nantahala Capital Management, LLC | 1,750,000 | $2.31M | 0.23% | 00.0% | Unchanged |
| OrbiMed Advisors LLC | 2,000,000 | $2.64M | 0.06% | 00.0% | Unchanged |
| Citadel Advisors LLC | 2,147,344 | $2.86M | 0.00% | −125,060−5.5% | Reduced |
| Lion Point Capital, LP | 2,340,207 | $3.09M | 9.67% | +40,000+1.7% | Added |
| Alta Fundamental Advisers LLC | 2,658,589 | $3.51M | 1.53% | +287,300+12.1% | Added |
| Millennium Management LLC | 2,749,930 | $3.66M | 0.00% | −105,682−3.7% | Reduced |
| RTW Investments, LP | 3,256,102 | $4.30M | 0.07% | 00.0% | Unchanged |
| BlackRock Inc. | 4,971,344 | $6.56M | 0.00% | 00.0% | Unchanged |
| Velan Capital Investment Management LP | 0 | $0 | 0.00% | −650,000−100.0% | Sold out |
| Monashee Investment Management LLC | 0 | $0 | 0.00% | −500,000−100.0% | Sold out |
| Bank of Montreal | 0 | $0 | 0.00% | −273,100−100.0% | Sold out |
| XTX Topco Ltd | 0 | $0 | 0.00% | −13,403−100.0% | Sold out |
| UBS Group AG | 0 | $0 | 0.00% | −2,618−100.0% | Sold out |
| ICA Group Wealth Management, LLC | 0 | $0 | 0.00% | −200−100.0% | Sold out |